Imelda Parker - Concepedia

Author

Imelda Parker

Cancer Trials Ireland ORCID

Also Known As

I Parker, I. Parker, I.T. Parker, Imelda Parker, Talley I. Parker

Publications

927

Citations

H-Index

Concepts

All Affiliations

Cancer Trials Ireland St. James's Hospital University Hospital Galway Beaumont Hospital Cork University Hospital

About

Imelda Parker is an author at Cancer Trials Ireland specializing in medicine, cancer research, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	375
2	Gastroenterology	4	4	182
3	Health Sciences	3	3	165
4	Emergency Medicine	1	1	21
5	Hepatology	1	1	142

Imelda Parker

Publications

873

Citations

H-Index

Page 1

	Year	Citations
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) Brian O’Neill, S M Griffin, C. Mariette, BMC Cancer	2017	156
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill, The Lancet. Gastroenterology & hepatology	2023	155
Viral pathogenesis of hepatocellular carcinoma in the United States T. Jake Liang, Lennox J. Jeffers, K. Rajender Reddy, Hepatology Viral PathogenesisHepatitis BPathologyImmunologyHepatitis B Virus	1993	142
Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452). John V. Reynolds, Shaun R. Preston, Brian O’Neill, Journal of Clinical Oncology Surgical OncologyEsophageal CancerCancer ManagementGastroenterologySurgery	2021	113
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer Khairun I. Abdul-Jalil, Katherine M. Sheehan, Joan Kehoe, Colorectal Disease	2013	47
(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis K. A. Lee, Mary Dunne, Cormac Small, Acta Oncologica	2018	34
ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction. Niamh M. Keegan, Fionnuala Keane, Sinéad Cuffe, Journal of Clinical Oncology Randomized Clinical TrialSurgical OncologyEsophageal CancerNeoadjuvant TherapyCancer Management	2014	33
ICORG 05-03: Prospective Randomized Non-Inferiority Phase 3 Trial Comparing Two Radiation Schedules in Malignant Spinal Cord Compression not Proceeding with Surgical Decompression P. Thirion, Lydia O’Sullivan, A. Clayton-Lea, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologySurgical OncologySpinal Cord InjuryRadiation SchedulesSpinal Tumor	2014	30
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression P. Thirion, Mary Dunne, Paul Kelly, British Journal of Cancer	2020	26
Edema of the brain following circulatory arrest C. G. Gunn, G. Rainey Williams, Imelda Parker Journal of Surgical Research NeurophysiologyMedicineTraumatic Cardiac ArrestIntracranial PressureBrain Injury	1962	21

Page 1